Speaking on the occasion Mr. Sanjay Agarwal, Managing Director of Magnatek said, “This year again we have participated in METASURG 2012 and as expected we have reached a wide range of potential customers and partners during this national event. We have showcased our product enhancements and new range of products added to our list recently”.

Magnatek has displayed its latest range of Bariatric OT Table products including Bariatric OT Table, Bariatric Mattress, Bariatric Grip Assistance, Bariatric Wheel Chair, Bariatric Wheel Chair Cum Trolley, Bariatric Hoist, Bariatric Walker, Bariatric Shower Bed, Bariatric Commode Chair, Bariatric Stretcher, Bariatric Wide Chair, Bariatric Examination Couch, and Bariatric Wheel Chair cum Stretcher cum Trolley. Magnatek Enterprises has one of the widest range of Bariatric OT Table Accessories in India.

More information on Magnatek products can be found at following links

http://www.magnatekenterprises.com/bariatric-ot-table-overview

http://www.magnatekenterprises.com/bariatric-operating-table

http://www.magnatekenterprises.com/bariatric-support-accessories

If you have missed meeting us at the event you can schedule a call or one to one meeting with representative of Magnatek. Please send a mail to Ms. Puja at puja@magnatekenterprises.com

About Magnatek

Magnatek Enterprises is a Hyderabad India based medical equipment company with dealers across India. Magnatek Enterprises and its group companies are manufacturing & marketing sophisticated medical equipments for the last four decades. Our close association with the medical fraternity inspired us to manufacture and market imaging and Operation Theater (OT) equipment which best suited the needs and requirements of the doctors and surgeons across India. Magnatek Enterprises specializes in OT equipment like fully automatic remote controlled multi-procedure C-Arm Imaging Surgical Tables, wide range of Operating Room Tables and OT Table accessories, OR pendants, ICU Pendants, Operation Theater Lights, LED OT Lights, Shadow less Halogen Lights, Dialysis Chairs, and Patient transfer Systems.

About METASURG 2012

METASURG 2012 is the leading International Conference on Bariatric & Metabolic Surgery that was held at Poona Hospital, Pune, India from Jan 7-8, 2012

Media Contact

For information about Magnatek you can contact:

Ms. Puja Agarwal
Director Marketing
Magnatek Enterprises,
#97,S.V.C.Indl. Estate,
Balanagar,Hyderabad – 500037,
Andhra Pradesh,India
Ph: 91-40-66668036/ 65501094 ,
Fax : 91-40-66668037
Email: puja@magnatekenterprises.com
www.magnatekenterprises.com

Speaking on the occasion Mr. Sanjay Agarwal, Managing Director of Magnatek said, “This year again we are participating in Medicall 2011 and we expect to reach wide range of potential customers and partners during this national event. We are looking forward to shawcase our latest product enhancements and new range of products added to our list”.

Magnatek will be showcasing its latest range of Indian and C Arm OT Tables spacialized for Orthopedics, Cardio thoracic, Neurology, Laparascopy, Bariatrics, Pediatrics , Angiography and Multiprocedure surgeries. We will also be displaying the latest range of shadowless Halogen and LED OT Lights, OR and ICU pendants and other OR solutions.

More information on Magnatek products can be found at following links

http://www.magnatekenterprises.com/ot-tables

http://www.magnatekenterprises.com/ot-lights

http://www.magnatekenterprises.com/overhead-pendants

Venue of Medicall 2011

You can see Magnatek in the Medicall 2011. We welcome you to the venue which is:

Medicall 2011
Chennai Trade Center
Chennai, Tamilnadu, India

To schedule a one to one meeting with Mr. Sanjay Agarwal, Director of Magnatek please send a mail to Ms. Puja at puja@magnatekenterprises.com

About Magnatek

Magnatek Enterprises is a Hyderabad India based medical equipment comapny with dealers across India. Magnatek Enterprises and its group companies are manufacturing & marketing sophisticated medical equipments for the last four decades. Our close association with the medical fraternity inspired us to manufacture and market imaging and Operation Theater (OT) equipment which best suited the needs and requirements of the doctors and surgeons across India. Magnatek Enterprises specializes in OT equipment like fully automatic remote controlled multi-procedure C-Arm Imaging Surgical Tables, wide range of Operating Room Tables and OT Table accessories, OR pendants, ICU Pendants, Operation Theater Lights, LED OT Lights, Shadowless Halogen Lights, Dialysis Chairs, and Patient transfer Systems.

About Medicall 2011

Medicall is organized by Medexpert Business Consultants Pvt. Ltd. Promoted by Dr. Manivannan, the Joint Managing Director of Kavery Medical Center and Hospital a 400 bedded Hospital in South India.

This hospital was started 11 years back with 30 beds by young professionals with limited knowledge about hospital industry. They faced many hurdles in the course of their growth. Medicall was born with the idea to share their expertise with the fellow medical fraternity.

Mr. Sundararajan, The Project Director of the Event has over 15 years of experience in the exhibition industry. He is only assisted by a team of dedicated young professionals. Since MEDICALL is being organized by people who have been in this field for many years, the content and the quality of the visitors are expected to be better than any other previously held event.

More about event can be found at: www.medicall.in

Media Contact

For information about Magnatek and visiting us during Healthtex 2011 you can contact:

Ms. Puja Agarwal
Director Marketing
Magnatek Enterprises,
#97,S.V.C.Indl. Estate,
Balanagar,Hyderabad – 500037,
Andhra Pradesh,India
Ph: 91-40-66668036/ 65501094 ,
Fax : 91-40-66668037
Email: puja@magnatekenterprises.com
www.magnatekenterprises.com

Healthex is an International exhibition focussing on Hospital, Medical & Surgical Equipments, Materials, Supplies & Allied Services. The show presents a complete range of Equipments, materials, services, Processes, Systems, Components, Consumables which find wide use in medical surgeries, Hospitals, Clinics, Diagnostic Centres from across the world.

Speaking on the occasion Mr. Sanjay Agarwal Managing Director of Magnatek said, “This is the second year we are participating in Healthex and we expect to reach wide range of potential customers and partners during this national event. We are looking forward to shawcase our lated product enhancements and new range of products added to our list”.

Magnatek will be showcasing its latest range of Indian and Imported OT Tables spacialized for Orthopedics, Cardio thoracic, Neurology, Laparascopy, Bariatrics, Pediatrics , Angiography and Multiprocedure surgeries. We will also be displaying the latest range of shadowless Halogen and LED OT Lights, OR and ICU pendants and other OR solutions.

More information on Magnatek products can be found at following links

http://www.magnatekenterprises.com/ot-tables

http://www.magnatekenterprises.com/ot-lights

http://www.magnatekenterprises.com/overhead-pendants

Media Contact

For information about Magnatek and visiting us during Healthtex 2011 you can contact:

Ms. Puja Agarwal
+91-40-65501094
sales@magnatekenterprises.com

Website: www.magnatekenterprises.com

PR Partner – We Submit Online

pr@wesubmitonline.com

Bangalore, INDIA, [June 24, 2011]: AS RELEASED BY Reactive Systems, Inc. Cary, NC; June 23, 2011: Reactive Systems, Inc. announced the V2011 release of its Reactis® testing and validation package for Simulink®/Stateflow® models. The new version includes many new features and enhancements to both Reactis and the Reactis for C Plugin. Some highlights are as follows.

Reactis

A simplified Reactis Tester launch dialog makes it even easier to generate tests from a model. The user may now specify how long automatic test generation should last by giving a maximum run time or maximum number of simulation steps to take while constructing the test vectors. The old launch parameters are also still available.

When running Reactis-generated tests either in Reactis Simulator or in Simulink using the runtests utility, Reactis compares the values computed by a model for top-level output ports and for test points against the values stored in the test suite for those items. Any differences are flagged. Reactis has always supported a global tolerance for performing these comparisons to avoid flagging small rounding errors. A new feature in V2011 enables the specification of a different tolerance for each output or test point.

A new search facility lets you perform a text search of your model for strings matching a pattern you specify. You can easily search Simulink block names and parameters, Stateflow state names and actions, Reactis Validator objective names, configuration variable names, and C code (if you are using the Reactis for C Plugin).

Additionally in V2011:

• Model initialization speed is improved for some models.
• Right-clicking on a system in the hierarchy panel offers an option “Copy System Path” which will copy the system path of that subsystem to the clipboard.
• When extracting a subsystem, the user can select whether or not to include any triggering mechanism for the subsystem in the extracted model.

The following Simulink features are newly supported in V2011:
• Initial support for MATLAB R2011a models.
• Newly supported blocks: Rate Limiter, Function-Call Split, Function-Call Feedback Latch.
• Support enumerated types and values in S-Functions and Legacy Code blocks.

Reactis for C Plugin

V2011 also includes a number of new features in the Reactis for C Plugin. Some highlights are as follows.

• Comments and inactive C code within #ifdef statements are colored differently to differentiate them from exercised code.
• Improved reachability analysis to identify and highlight dead code.
• Allow (small) numeric arrays to be added as watched variables.
• Produce a warning if:
o the result of an expression with no side-effects is ignored.
o a non-void function does not return a value.
o __declspec and __attribute clauses are used.

About Reactis: Reactis provides automated test-generation and model-validation capabilities for Simulink/Stateflow models of control software. The tool can be used to test for conformance between a model and implementation code, and it can also be employed to validate model behavior. Reactis is used at dozens of companies worldwide in the automotive, aerospace, and heavy equipment industries.

About Lanika Solutions

Lanika Solutions is provider of technical computing software & high-end hardware tools for engineers and scientists in industry, government and education. The Company partners with reputed principals developing industry leading solutions that help a wide base of clients throughout the Indian sub-continent solve the toughest engineering problems.

Visit www.lanikasolutions.com to learn more.

About Reactive Systems

Reactive Systems, founded in 1999, is a privately held company with offices in Cary, NC and Nagoya, Japan. The company offers tools and services to help improve software quality while reducing development costs.

Visit www.reactive-systems.com to learn more.

Bangalore, INDIA, [April 27, 2011] – Lanika Solutions, provider of world-renowned technical products that contribute to the success of engineering projects has entered a distribution agreement with Reactive Systems, Inc. the leading provider of tools and services for embedded-software testing and validation.

Lanika Solutions will sell and provide front-line technical support for all Reactive Systems products including Reactis, the Reactis for C Plugin, and Reactis for C. All products help engineers increase the quality of embedded software while decreasing verification and validation costs. The first two products support a model-based design process while the later supports a C-code process.

Reactis provides advanced verification and validation of Simulink models through automated test generation, requirements checking, and advanced debug. The Reactis for C Plugin offers white-box testing of the C code portions of models (S-Functions and Stateflow custom code). Reactis for C generates comprehensive yet compact tests from C code, finds runtime errors, and tracks coverage.

“We are very pleased to be partnering with Lanika Solutions,” noted Reactive Systems CEO Steve Sims. “Their considerable expertise with software tools for engineering, science, and math positions Lanika very well to sell and support all of our products.”
“We are delighted to enter this partnership with Reactive Systems having varied experience in providing robust, cutting-edge technology solutions especially in embedded-software testing and validation,” says Zakir Hussain, Director of Lanika Solutions. “Through our association, we shall further extend our reach in Indian markets by introducing these tools which will greatly benefit our clients.”

About Lanika Solutions

Lanika Solutions is provider of technical computing software & high-end hardware tools for engineers and scientists in industry, government and education. The Company partners with reputed principals developing industry leading solutions that help a wide base of clients throughout the Indian sub-continent solve the toughest engineering problems.
For more information, visit www.lanikasolutions.com
About Reactive Systems

Reactive Systems, founded in 1999, is a privately held, US-based company. Its products are used by companies around the world in the automotive and aerospace industries as well as in academia.

For more information, visit www.reactive-systems.com

For Sample Pages, please click or add the below link to your browser:

http://www.gbiresearch.com/RequestSamplePages.aspx?ID=Top-10-Healthcare-Trends-in-2011&Title=Medical_Devices&ReportType=Industry_Report

However, the increased use of targeted/personalized therapies such as Herceptin, first-time innovations such as cancer vaccines and longer treatment periods for growing number of patients, have contributed positively to the growth of this market.

With more than 80 molecules in the late-stage development findings of innovative treatment for niche segments and the evolution of new cancer segments, cancer therapeutics market continues to attract investments from pharmaceutical companies.

The global pharmaceutical industry is currently witnessing rapid expansion with advances in manufacturing processes, technology innovation and integration. The ever increasing financial woes of the pharmaceutical industry have provided a huge opportunity to contract outsourcing organizations to capitalize on the combined advantage of their expertise and economies of scale.

Contract research organizations will emerge as strategic partners for biopharmaceutical companies. The service models of the contract research organizations are evolving to become more functional, where services are outsourced based on the analysis of their core competencies.

The drug discovery markets in India and China are set to grow at double digit rates, with rapid developments in the market landscape and changing market dynamics in the global pharmaceutical industry. According to industry experts, India and China typically provide cost advantages of up to 60–70% in drug discovery research. Other major benefits include availability of skilled manpower, the scale of available resources to conduct clinical trials and the improved state of intellectual property protection in the two countries.

GBI Research, the leading business intelligence provider, has released its latest report, “Top 10 Healthcare Trends in 211” that provides key data, information and analysis of the major trends in the biopharmaceutical and medical devices industry. The report provides a comprehensive insight into the ten major trends in biopharmaceutical and medical devices industry in 2010. A detailed analysis of each of the major trends is presented in the report.

For further details, please click or add the below link to your browser:

http://www.gbiresearch.com/Report.aspx?ID=Top-10-Healthcare-Trends-in-2011&ReportType=Industry_Report&coreindustry=ALL&Title=Medical_Devices

Visit our report store: http://www.gbiresearch.com

For more details contact:
pressreleases@gbiresearch.com
North America: +1 646 395 5477
Europe: +44 207 753 4299
+44 1204 543 533
Asia Pacific: +91 40 6616 6782

{TO BE USED FOR: PRE-INSURANCE POLICY CHECKUP /
EMPLOYMENT SCREENING / CLINICAL TRIALS}

The Nano-Check™ Nicotine test is a rapid, self-controlled immunoassay for the qualitative detection of cotinine in human urine. Cotinine is a primary metabolite of nicotine and remains in the body of habitual tobacco users for approximately 17 hours. The cutoff concentration of this test is 200 & 500 ng/ml of cotinine. This in-vitro assay is intended for professional use.

{cotinine levels more than 10 ng/mL are considered to be consistent with no active smoking. Values of 10 ng/mL to 100 ng/mL are associated with light smoking or moderate passive exposure, and levels above 300 ng/mL are seen in heavy smokers – more than 20 cigarettes a day. In urine, values between 11 ng/mL and 30 ng/mL may be associated with light smoking or passive exposure, and levels in active smokers typically reach 500 ng/mL or more.)

Easy to use

• Simple one step assay

• Urine based immunochromatography

• Small sample volume, 80 ul

• Result read visually

• With Nano-Checker 710 reader, results are automatically determined and displayed    or printed as “Positive” or “Negative”

• Accurate and Consistent Quality

• Rigorous Quality Control system

• FDA Approved

We are offering Nicotine / Cotinine Urine Rapid Test Kits.

More info: contact us on  022-26731904 / 26731052 Ext # 35

Or write us on :

santosh.sahu@pammvi.com/mansi.gurav@pammvi.com/enquiry@pammvi.com

Pammvi Group Of Companies

C-501, Remi Bizcourt, 9, Shah Ind Estate,

V.D Road, Andheri (w), Mumbai – 53.

Board: 022-26731904 / 26731052 Ext # 35

Fax: 022-26731901

http://www.pammvi.com/divisions.aspx?catid=9

http://www.nicotine-test.blogspot.com/

December 8th 2010, Hyderabad; ASICON 2010 / ASITECH will be held during 115- 20 December, 2010 at All India Institute of Medical Sciences New Delhi. Magnatek will participate in the event and will show its latest Operating Room Solutions at the ASICON 2010 / ASITECH.

ASICON2010 is the 70th Annual Conference of the Association of Surgeons of India, being held at asicon City, AIIMS Campus, New Delhi, India from December 15 – 20, 2010. The conference is organized by Delhi State Chapter and the Association of Surgeons of India. More details about ASICON2010 can be found at its website www.asicon2010.org.

ASITECH is the International Medical Technology Show being organized as a part of the 70th Annual Conference of the Association of Surgeons of India being held at the premises of All India Institute of Medical Sciences, New Delhi, India from December 15-20, 2010. It is expected to be attended by over 10,000 Surgeons and related professionals from India and neighbouring countries.

Magnatek Enterprises will put up their stand at ASICON 2010 / ASITECH New Delhi to display its latest products at the event which include:

* Operation Theatre Tables (Indian & Imported)
* LED Lights, Halogen Lights
* Overhead Pendants
* Patient Transfer Systems

Visit Magnatek at ASICON 2010 / ASITECH

Stall No: 89
ASICON 2010 (ASITECH)
All India Institute of Medical Sciences
AIIMS, New Delhi

Date : ( 15- 20 December, 2010)

Participating surgeons of the ASICON 2010 can visit the stall or can visit our stall for the demonstration of Magnatek products and the latest trends in Operating Room Solutions. To schedule a personal demonstration / meeting with us you can contact

sales@magnatekenterprises.com

Learn more about Magnatek at ASICON 2010 / ASITECH

About Magnatek

Magnatek Enterprises is a Hyderabad India based medical equipment comapny with dealers across India. Magnatek Enterprises and its group companies are manufacturing & marketing sophisticated medical and imaging equipments for the last four decades. Our close association with the medical fraternity inspired us to manufacture and market imaging and Operation Theater (OT) equipment which best suited the needs and requirements of the doctors and surgeons across India. Magnatek Enterprises specializes in OT equipment like fully automatic remote controlled multi-procedure C-Arm Imaging Surgical Tables, wide range of Operating Room Tables and OT Table accessories, OR pendants, ICU Pendants, Operation Theater Lights, LED OT Lights, Shadowless Halogen Lights, Dialysis Chairs, and Patient transfer Systems.

Magnatek Media Contact

Puja Agarwal
Magnatek Enterprises,
#97,S.V.C.Indl. Estate,
Balanagar,Hyderabad – 500037,
Andhra Pradesh,India
Ph: 91-40-66668036/ 65501094 ,
Fax : 91-40-66668037
www.magnatekenterprises.com

Speaking on the ocassion Mr. Sanjay Agarwal, Director of Magnatek indicated, “The participation in Hospital Infrastructure India 2010 with our partner GMP Technical Solutions has enabled us to showcase our products to prospective customers in India especially those from Mumbai region. We are very happy with the kind of response we are getting for our oroducts in this premier event”

You can see Magnatek and GMP products at the prime location stall Stall No. A17 in the Hospital Infrastructure India 2010. We welcome you to the

Hospital Infrastructure India 2010
Stall No. A17
7- 9 December 2010,
Bombay Exhibition Center, India
751/5th Floor Solitaire Corporate Park
Andheri Kurla Road Chakala,
Andheri (E) Mumbai – 400093 ( India)

Learn more about Magnatek at Hospital Infrastructure India 2010

About Magnatek

Magnatek Enterprises is a Hyderabad India based medical equipment comapny with dealers across India. Magnatek Enterprises and its group companies are manufacturing & marketing sophisticated medical and imaging equipments for the last four decades. Our close association with the medical fraternity inspired us to manufacture and market imaging and Operation Theater (OT) equipment which best suited the needs and requirements of the doctors and surgeons across India. Magnatek Enterprises specializes in OT equipment like fully automatic remote controlled multi-procedure C-Arm Imaging Surgical Tables, wide range of Operating Room Tables and OT Table accessories, OR pendants, ICU Pendants, Operation Theater Lights, LED OT Lights, Shadowless Halogen Lights, Dialysis Chairs, and Patient transfer Systems.

About Hospital Infrastructure India 2010

Hospital Infrastructure India 2010 – India’s premier international exhibition on Hospital infrastructure, hospital supplies / planning and healthcare development, that is scheduled to take place during December 7-9, 2010 at Bombay Exhibition Centre, Mumbai, India. Hospital Infrastructure India, is part of our global brand “Hospital Build” that we regularly organise in Dubai & Singapore.

Hospital Infrastructure India is brought to you by the organisers of one of the world’s largest healthcare exhibitions – Arab Health- the HOSPITAL INFRASTRUCTURE INDIA EVENT- is setting new standards within the industry as a premier regional event with international appeal, attracting exhibitors, visitors and delegates from across the globe. Hospital Infrastructure India, a high profiled international event on hospital infrastructure, has already started receiving a good response from the industry.

The steering committee of the event has some of the leading names within the industry:

Dr. Baljit Singh Bedi – Advisor Health Informatics, C-DAC, Ministry of Communications and IT, Govt. of India
Mr. Vijay Garg – Joint Hon. Secretary, The India Institute of Architects
Dr. Prem C Jain – CMD, Spectral Services Consultants Pvt. Ltd.
Dr. Vivek Desai – Managing Director, HOSMAC
Mr. Peter D’souza – Chief Engineer, Lilavati Hospital
Dr. R. A. Bhalerao – Director, Medical Planning & Project, PD Hinduja National Hospital
Dr. V M P Thomas – General Manager, Operations & Projects, Dr L H Hiranandani Hospital
Mr Sunil Relia – President, Academics With Excellence Spectrum Of Maintenance Engineers, (AWESOME)
Air Marshall Lalji K Verma – President, Indian Society Of Hospital Waste Management (ISHWM)
Dr. Bhupendra Kumar Rana – Deputy Director, NABH
Dr. S Gurushankar – Vice Chairman, Federation of Hospital Administrators

Year on year, the Hospital Build exhibition & congress, held in Dubai & Singapore is hailed as a resounding success and considered to be exceptionally rewarding for both exhibitors and sponsors. This success is achieved through an extensive marketing and promotion programme, strictly aimed at specific target sectors of the healthcare industry, bringing together exhibitors and key industry decision makers to create the most conducive business-to-business environment.

the participants in the event include representative from

1) Hospital, medical centers & clinics
2) Healthcare Government of India
3) Architects & Designers
4) Hospital Suppliers
5) NGO & Humanitarian Organisations

More about event can be found at: www.hospitalinfra-india.com

Magnatek Media Contact

Puja Agarwal
Magnatek Enterprises,
#97,S.V.C.Indl. Estate,
Balanagar,Hyderabad – 500037,
Andhra Pradesh,India
Ph: 91-40-66668036/ 65501094 ,
Fax : 91-40-66668037
www.magnatekenterprises.com

The days when the Indian pharmaceutical industry was synonymous with cheap generic drug production are passing. While generics continue to play a major part in the industry’s success, many companies have started down the long road of drug discovery, novel product development and pharma services. With high-quality research, low-cost manufacturing facilities and educated personnel, the Indian pharmaceutical industry presents both a competitive threat and partnering opportunities. ( http://www.bharatbook.com/detail.asp?id=160235&rt=The-Indian-Pharmaceutical-Industry-New-Strategies-in-a-Changing-World.html )

A significant international industry
India is the world’s fourth largest producer of pharmaceuticals by volume, accounting for around 8% of global production. In value terms, production accounts for around 1.5% of the world total. The Indian pharmaceutical industry directly employs around 500,000 people and is highly fragmented. While there are around 270 large R&D based pharmaceutical companies in India, including multinationals, government-owned and private companies, there are also around 5,600 smaller licensed generics manufacturers, although in reality only around 3,000 companies are involved in pharmaceutical production. Most small firms do not have their own production facilities, but operate using the spare capacity of other drug manufacturers.

A new approach
The advent of pharmaceutical product patent recognition in January 2005 changed the ground rules for Indian companies. In the run up to the new post-patent era and since, the Indian industry has been evolving. R&D departments are moving away from reverse-engineering in favour of developing novel drug delivery systems and discovery research. It is anticipated that the experience of selling generics in the international market will hold Indian companies in good stead for selling their own branded products to these markets in the future.

Focus on…current and future markets
The dynamics of the domestic Indian market have always encouraged Indian industry to pursue overseas lines of business. Expansion comes at a cost and some companies have had to restructure. In June 2009, Wockhardt divested its German business, esparma and more recently, in March 2010, Orchid sold its generic injectable formulations business to Hospira but came out of the deal with a long term supply agreement for its APIs.

INDIA
India remains an important market for the vast majority of Indian companies. The indigenous industry supplies around 70% of the country’s pharmaceuticals. The proportion of revenue derived from India depends largely on the strategy of the individual company and its penetration into overseas markets. For example, while Zydus Cadila aims to grow rapidly overseas, India remains its most important market, accounting for 55.8% of revenue in fiscal 2008/09. India is also Cipla’s key market, generating almost half of the company’s revenue in 2008/09, although this percentage has been declining in recent years as the company has increasingly targeted overseas markets. Other companies, such as Dr. Reddy’s, are less reliant on the Indian market; in 2008/09, India contributed just 17% of the company’s global revenue.

For more information kindly visit : The Indian Pharmaceutical Industry : New Strategies in a Changing World

Related Reports

Pharmaceuticals: Global Industry Overview

http://www.bharatbook.com/detail.asp?id=134348&rt=Pharmaceuticals-Global-Industry-Overview.html

Pharmaceuticals – Global Group of Eight (G8) Industry Guide

http://www.bharatbook.com/detail.asp?id=135896&rt=Pharmaceuticals-Global-Group-of-Eight-G8Industry-Guide.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook

New York: With so many lives around the world being transformed and saved by Dr. Pankaj Naram, world-renowned Siddha Veda Master, the Ecumenical Medical-Humanitarian Order will give him their highest honor, and induct him into the Knights of St John of Jerusalem (“Knights of Charity”) on November 14th 2010 for his work of healing and lifting humanity.

Dr. Pankaj Naram is best known for helping and healing over One Million people from more than 108 countries, including many noted individuals (such as the Dalai Lama, Mother Theresa, and a number of heads of state worldwide). Dr. Naram is a super-specialist in helping people overcome common and rare conditions, including Arthritis, Diabetes, High Blood Pressure, Asthma, Psoriasis, Depression, Anxiety, Phobias, Cancer, HIV, Heart Problems, Stroke, Ulcerative Colitis, Chronic Fatigue Syndrome, Fibromyalgia, Obesity, Skin Issues, Hair Loss, Kidney Problems, ADD, ADHD, Autism.

What not many people know about Dr. Naram is how many humanitarian projects he sponsors, including:

Over 350 HIV patients are being treated in India, free of charge. Their treatment includes all Ancient Secrets Herbal Formulas, laboratory testing and necessary Panchakarma treatments. Having heard of Dr. Naram’s success in treating HIV patients, Mother Teresa approached him and asked for his assistance in creating an HIV hospital. Unfortunately, Mother Teresa passed away before this dream could be realized but Dr. Naram’s work carries on.

Dr. Naram works directly with Serving Those Who Serve (www.stws.org), a non-profit organization in New York dedicated to the health and well being of workers and Volunteers who served at Ground Zero and related sites. More than 1000 people exposed to toxins following the terrorist attacks of 9/11 are being treated with the most incredible results. This project was funded by Dr. Naram as gift to the brave men and women who risked their lives to save the lives of others.

Three schools providing medical care and education for children with sponsored through Dr. Naram’s Foundation. The students of these schools are trained and integrated into everyday social settings. Many now enjoy a healthy family life and hold regular jobs.

Dr. Naram’s love for animals has led to providing thousands with care and treatment and freeing them from pain and discomfort. This has always been a major part of his lineage’s belief system and practice. After learning of the imminent shut down by the order of government due to lack of funds of three veterinary hospitals, Dr. Naram immediately responded by taking over the management and funding of the hospitals, saving the lives of many animals that would have otherwise been put down, due to the closures.

Reforestation and replenishing plants and vegetation that are being used to create formulations is another passion of Dr. Naram’s. A substantial amount of funding has always been delegated to reforestation projects.

“After having traveled the world, knowing healers from so many traditions, I can say Dr. Naram is the most powerful healer I have ever met.” ~Joseph Sugarman, Author and President of multiple companies that focus on health & longevity

For more information visit :
http://www.ayushakti-usa.com

Bangalore, INDIA, [November 10, 2010] — Lanika Solutions and Visualization Sciences Group (VSG) are pleased to announce the release of the 6.3 version of Avizo, the visualization and analysis software for scientists and engineers. Bringing many improvements both on performance and usability, Avizo represents an essential step in VSG’s continuous efforts to deliver even more powerful and easier-to-use 3D data analysis tools.

This minor release of Avizo focuses mainly on improvements of the Avizo Wind edition for providing a better support of CAE data sets. It includes also some bug fixing and performance improvement.

Avizo Wind Edition – Improvements and New Features includes all CAE and FEA importers such as Abaqus, Ansys, Nastran, have been improved to support: Displacement vectors, Strain tensors and Stress tensors.
• For more information on what’s new in Avizo 6.3, read: Avizo 6.3 Release Notes (PDF)

“VSG has just released a new minor version of Avizo (6.3) containing several improvements concerning the CAE and FEA file imports (Abaqus, Ansys, …)”, says Pascal Doux, VSG Product Director. “This version also includes a new OpenFoam file reader, some bug fixes as well as performance improvements. This minor version prepares the next major version Avizo 7.0 scheduled early next year.”

“This new release of Avizo (6.3) demonstrates VSG’s commitment to continuously improvise their products based on the feedbacks from our users.” says Zakir Hussain, Director of Lanika Solutions. “All Avizo users who benefit from our Maintenance Service are going to be directly delivered with an electronic copy of their update to Avizo 6.3.”

About Lanika Solutions
Lanika Solutions is a leading provider of high-performance technical software & hardware tools for engineers and scientists across Industries and academia. Its product offerings and support reflects the philosophy that given great tools, clients can simplify development, increase productivity, and dramatically reduce time to market. Lanika Solutions’ suites of technical products help clients to quickly solve practical problems within the framework of the premier products and services they provide.

Lanika Solutions partners with reputed principals developing industry leading solutions. Currently, Lanika Solutions is partnered with Visualization Sciences Group (VSG), Maplesoft, Lyrtech, Breault Research Organization (BRO), ExpertControl, Sigma Technology and DCM/ CEATI International. Lanika Solutions’ offerings have been selected as the leading products available to scientists and engineers in their respective application areas. Lanika Solutions will continue to expand its offerings through organic growth in related technology/market segments as other premium solutions become available.

For more information, visit www.lanikasolutions.com

About Visualization Sciences Group

VSG – Visualization Sciences Group is the leading provider of high-performance 3D visualization software and toolkits for engineers, scientists‚ and application developers. VSG provides advanced 3D software technologies for scientific data visualization‚ engineering and simulation, materials science and earth sciences.

For more information, visit www.vsg3d.com

Avizo is a registered trademark of VSG, Visualization Sciences Group. All other products mentioned may be trademarks or registered trademarks of their respective holders.

Lawrence & Mayo, the leading Optical retailer is spreading happiness among its consumers through a fabulous “Happiness guaranteed offer” for all who require progressive spectacles.

Progressive lenses are the ideal solution for people age 40 and older needing help viewing multiple distances. Unlike the outdated design of bifocal lenses, progressive lenses have no lines, helping wearers to have a better cosmetic appearance and improved vision while wearing their eyeglasses. This season from 1st October to 31st December 2010, there are a choice of two offers on Progressives at Lawrence & Mayo.

Buy a Varilux progressive lens and get a gift voucher worth Rs. 500/- absolutely free. So those requiring progressives opt for Varilux, one of the best progressive designs.

Also, those wearing bifocals, it’s a great opportunity to upgrade and get progressive! Switch to progressives starting from just Rs.2999/-. Guess what, we also provide accommodation warranty of 1 month. In case you’re unable to adapt to the lenses within a month, we’ll replace it, that’s our guarantee.

Avail these exclusive offers only at Lawrence & Mayo stores.

About Lawrence and Mayo: (http://www.lawrenceandmayo.co.in): Lawrence & Mayo is a two divisional company, pioneers in ophthalmic optics & instrumentation. We have entered in our third century of operations and are poised to make rapid strides in the 21st century. Established in 1877, we have carved a niche for ourselves as India’s leading manufacturing and dispensing optician, with diversification in scientific and industrial instrumentation. Today, we stand tall and are well-equipped to meet the needs of the rapidly growing market for eye care and precision instruments .Having specialized in the fields of engineering, scientific and vacuum instruments, our core success lies in its professionalism.

Contact details: Press release issued on behalf of Mr Vivek Mendonsa (vivekm@lawrenceandmayo.co.in) Marketing Director, Lawrence and Mayo, by Social Wavelength (www.socialwavelength.com). For any clarification please contact pbiraia@socialwavelength.com. (9619307447)

Chennai, India (Novemer 2010); Nucletron, a leading provider of state of the art radiotherapy solutions for cancer treatment, will be opening the Nucletron India Training Academy (NITA) at Chennai on November 16th, 2010.

Funded by Nucletron & the Dutch government, NITA will provide professional training to Radiation Oncologists and Medical Physicists in the region.

NITA will provide high-end treatment training, offer education and enhance medical professional expertise in the latest technology for radiation oncology treatment. This academy, one of its kind in India, is expected to result in improved care for cancer patients in this part of the globe.

NITA will provide an extensive tailored training around Nucletron’s solutions for both brachytherapy and external beam radiotherapy. The training will be specifically targeted to upgrade and update the skills of Radiation Oncologists and Medical Physicists in the use and application of treatment planning systems and brachytherapy remote after-loaders.

The course curriculum is carefully designed to enhance the knowledge and develop confidence in using the various Nucletron products and solutions. The trainings are to be conducted by highly experienced experts who have spent years in understanding the current clinical needs of the radiation oncology space.

“The Nucletron India Training Academy is a great initiative to improve the knowledge level and clinical experience in the latest technology for cancer treatment,” said Dr. A. Vasanthan MD, Chairman, Dept of Radiation Oncology & Additional Director, Cancer Institute, Adyar, Chennai, India. “I am convinced that NITA will have a positive effect on the expertise in precision cancer treatment in this region, ” he added.

“We are very happy to be able to provide radiation oncologists and medical physicists with specific training to improve their skills in treating and beating cancer,” says B. Viswanathan, Managing Director at Nucletron India. “With this support to our customers we are able to ultimately improve care for many cancer patients in this region.”

About Nucletron (www.nucletron.com)

Nucletron provides state of the art radiotherapy solutions for cancer treatment, that meet the evolving needs of patients, their caregivers and healthcare professionals around the world. Nucletron has unmatched global leadership in brachytherapy, a very precise, highly effective and well-tolerated treatment option for healthcare providers, tailored to the needs of individual patients. Headquartered in Veenendaal, The Netherlands, Nucletron employs more than 500 employees, with offices in 15 countries, and products available in more than 100 countries around the world.

For more information, please contact Murali, 9840935357, mediaworks@hrworkshop.in

Bangalore, INDIA; 29 October 2010: Lanika Solutions is pleased to announce the launch of MapleSim™ 4.5, released by Maplesoft. MapleSim 4.5 is the latest version of the high-performance physical modeling and simulation tool. Based on advanced symbolic computation technology, MapleSim is an advanced engineering software tool for design, modeling, and high-performance simulation, including real-time and hardware-in-the-loop applications. Unlike traditional, numeric-based modeling tools, the unique symbolic approach of MapleSim exposes and provides access to the model equations.

The latest release includes enhanced support for Modelica®, an open standard for describing physical models and components that forms the basis of many components in MapleSim. With MapleSim 4.5, engineers can now access new collections of components using the Modelica import feature, seamlessly including third-party Modelica libraries and their own custom Modelica components in their MapleSim models. Libraries, components, and models based on the electrical, 1-D mechanical, signals, and thermal heat flow domains from the Modelica 3.1 Standard Library can be easily imported into MapleSim and included with standard MapleSim components and models. Other enhancements include the ability to convert older MapleSim models to use Modelica 3.1, the latest version of the Modelica Standard Library, so that these models can take advantage of the latest improvements.

MapleSim 4.5 includes an improved simulation engine that can readily simulate continuous models with discrete events. The enhanced engine handles a much larger class of these systems than earlier versions, and shows significant performance improvements for existing hybrid discrete/continuous models. With the improved engine, MapleSim can now handle models that include hundreds of events. Models with discrete events will often run 10 times faster than in MapleSim 4, with some models running over 100 times faster. The improved simulation engine also results in reduced formulation times for large continuous models, shortening the time the engine requires to prepare the model for simulation.

“With the expanded support for Modelica in MapleSim 4.5, and its increased capacity for modeling continuous systems with discrete events, engineers and researchers can apply MapleSim’s time-saving techniques to even more of their design problems, while educators can introduce students to an even wider variety of realistic examples,” says Dr. Laurent Bernardin, Chief Scientist and Executive Vice President of Research and Development at Maplesoft. “MapleSim helps engineers deal effectively with the increasingly complex designs found in advanced engineering projects, and helps students prepare to meet these challenges.”

“The improvements with MapleSim 4.5 demonstrate Maplesoft’s commitment in developing innovative products that benefit the engineering and scientific community.” says Zakir Hussain, Director of Lanika Solutions. “With the improvements in the product, our customers will greatly profit by significantly reducing their development cycles and solving complex design problems with ease.”

About Lanika Solutions

Lanika Solutions is a leading provider of high-performance technical software & hardware tools for engineers and scientists across Industries and academia. Its product offerings and support reflects the philosophy that given great tools, clients can simplify development, increase productivity, and dramatically reduce time to market. Lanika Solutions’ suites of technical products help clients to quickly solve practical problems within the framework of the premier products and services they provide.

Lanika Solutions partners with reputed principals developing industry leading solutions. Currently, Lanika Solutions is partnered with Maplesoft, Lyrtech, Visualization Sciences Group (VSG), Breault Research Organization (BRO), ExpertControl, Sigma Technology and DCM/ CEATI International. Lanika Solutions’ offerings have been selected as the leading products available to scientists and engineers in their respective application areas. Lanika Solutions will continue to expand its offerings through organic growth in related technology/market segments as other premium solutions become available.

For more information, visit www.lanikasolutions.com

About Maplesoft

Maplesoft™ is the leading provider of high-performance software tools for engineering, science, and mathematics. Its product suite reflects the philosophy that given great tools, people can do great things.

Maplesoft’s core technologies include the world’s most advanced symbolic computation engine and revolutionary physical modeling techniques. Combined together, these technologies enable the creation of cutting-edge tools for design, modeling, and high-performance simulation.

Maplesoft’s products help to reduce errors, shorten design times, lower costs, and improve results. The Maplesoft product suite includes Maple™, a technical computing and documentation environment, and MapleSim™, a high-performance, physical modeling and simulation tool.

Engineers, scientists, and mathematicians use Maplesoft products to enable them to work better, faster, and smarter. Maplesoft’s customers include Ford, BMW, Bosch, Boeing, NASA, Canadian Space Agency, Canon, Motorola, Microsoft Research, Bloomberg, and DreamWorks, covering sectors such as automotive, aerospace, electronics, defense, energy, financial services, consumer products, and entertainment. With Toyota, Maplesoft founded the Plant Modeling Consortium to promote the development of new design techniques for automotive and related industries.

For more information, visit www.maplesoft.com

METASURG 2010 is 3rd International Conference on Bariatric & Metabolic Surgery in Mumbai, India. METASURG is an unique event for surgical education in Bariatric & Metabolic Surgery offering cutting edge education taught by well known thought leaders in thins industry.

METASURG 2010 (Obesity Conference)
Hotel Courtyard Marriott
30th to 31st October 2010

Speaking on the ocassion Mr. Sanjay Agarwal Managing Director of Magnatek said – “If you are planning to buy a Bariatric Table – you must visit Magnatek stall and experience the the special features of Magnatek Bariatric OT Tables which include – Low Height of 25”, Steep head up tilt of 60 degrees, High Load Capacity of 200/350kgs, and Special attachments for patient sit up position.”

The Magnatek Enterprises intends to demonstrate its “OBESO – MATIC” specialized Obesity OT Tables at METASURG 2010 (Obesity Conference). To schedule a personal meeting with Sanjay Agarwal, Managing Director of Magnatek Enterprises please contact Ms. Puja at Ph: 91-40-66668036/ 65501094 or write to sales@magnatekenterprises.com

Media Contact

Puja Agarwal
Magnatek Enterprises,
#97,S.V.C.Indl. Estate,
Balanagar,Hyderabad – 500037,
Andhra Pradesh,India
Ph: 91-40-66668036/ 65501094 ,
Fax : 91-40-66668037
www.magnatekenterprises.com

Telemedicine Market in Brazil, Russia, India, China (BRIC) Countries is the new research report launched.

BRIC telemedicine market is witnessing a significant growth due to increase in the number of patients suffering from chronic diseases such as chronic obstructive pulmonary disease (COPD), chronic heart failure (CHF), asthma, hypertension, and diabetes. An increase in IT spending are identified as the key factors boosting demand for telemedicine in these countries. Moreover increasing demand for better healthcare services and growth in telecommunication network are also impacting BRIC telemedicine market.

The BRIC telemedicine market is classified based on the type of technology and services used. Technology market can further be divided on hardware used and network connectivity solutions. Here basic telemedicine platform and clinical devices are the major hardware in use.

BRIC telemedicine market is further analyzed on the basis of telemedicine applications such as Teleconsultation, Telecardiology and Teledermatology. Teleconsultation, Telecardiology and Teleradiology are the major telemedicine applications in BRIC countries. Telecardiology is very popular in India where as Teleradiology is more popular in Brazil after Teleconsultation. Teledermatology, Telesurgery and home telehealth are less in user and are in emerging stage.

The BRIC telemedicine is expected to reach a market size of $418.4 million by the year 2014, at a CAGR of 15.8% from 2009-2014. The BRIC telemedicine technology market is expected to reach a size of $307.4 million by the year 2014 growing at a CAGR of 16.6% from 2009-2014 and BRIC telemedicine service market will reach $111 million in 2014 with CAGR of 13.8%.

Market estimates and forecast :

The report provides in-depth market estimates and forecast for BRIC telemedicine market based on technology and types of services of telemedicine. Further technology market is segmented on the basis of hardware and network connectivity solutions. BRIC market is also analyzed on the basis of different application usage in telemedicine.

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

Powerful Research and Analysis :

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

For more information on the report, kindly visit :
http://www.visionshopsters.com/product/3364/Telemedicine-Market-in-Brazil-Russia-India-China-BRIC-.html

or email us your query at : info@visionshopsters.com
———————————————-

For further details, please click or add the below link to your browser:

http://www.globaldata.com/reportstore/Report.aspx?ID=Growth-Hormone-GH-eficiency-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare

The level of competition in the GHD market is strong. The current pharmacological therapies involve the administration of GH for the aim of treating GHD both in adult and pediatric patients. However, these therapies seem to be less effective in adult patients. The biosimilars used to treat GHD include Genotropin, Humatrope, Nutropin, Saizen and Norditropin. These agents are either GH secretagogues, synthetic hGH or GH releasers. The current market is well served by the present treatment options available, but the effective treatment for adult patients seems to be under question. The pharmaceutical and biotechnology players seem to overlook this largely untapped market.

The current treatment options for GHD do not seem to influence patients or physicians. Most of the marketed products available for the treatment of GHD are dosed once daily, which causes inconvenience among patients. This has been cited as the major reason for patients’ non-compliance to therapy. Thus, there is an urgent need for therapies which can decrease the frequency of administration and at the same time possess increased safety as compared to currently market products.

For further details, please click or add the below link to your browser:

http://www.globaldata.com/reportstore/Report.aspx?ID=Growth-Hormone-GH-eficiency-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare

Though most of the marketed products are meant for GHD treatment in adults and children, their use in adult patients seem to be ineffective other than for increasing muscle strength, reducing fat mass and improving metabolic profiles, which could predispose to cardiovascular disease. The most common side effects observed with somatropin replacement are hand swelling and stiffness, joint and muscle ache and the development of insulin resistance. Their potential long-term side effects are irreversible or can sometimes be even fatal. Some studies have also reported a higher cancer risk with increased GH activity or Insulin-like Growth Factor-1 (IGF-1) levels, which render safety a primary concern for GHD treatment developers. This implies that a risk-to-benefit ration needs to be determined more precisely while treating patients with GHD. Due to these issues, most of the physicians are conservative towards somatropin hormone replacement therapy and exercise caution while administering somatropin as a treatment.

GlobalData, the industry analysis specialist’s new report, “Growth Hormone Deficiency (GHD) -Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global growth hormone deficiency market. The report identifies the key trends shaping and driving the global growth hormone deficiency market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global growth hormone deficiency sector.

For further details, please click or add the below link to your browser:

http://www.globaldata.com/reportstore/Report.aspx?ID=Growth-Hormone-GH-eficiency-Drug-Pipeline-Analysis-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=ALL&Title=Pharmaceuticals_and_Healthcare

Visit our report store: http://www.globaldata.com/reportstore

For further details, please click or add the below link to your browser:

http://www.globaldata.com/reportstore/Report.aspx?ID=Global-Renal-Dialysis-Equipment-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=ALL&Title=Medical_Devices

Diabetes and hypertension both are well established risk factors for renal failure. More than 70% of the renal failure cases in the US and 35% of the renal failure cases in Europe occur due to pre-existing diabetes and/or hypertension. According to International Diabetes Federation (IDF), nearly 285 million people are suffering from Diabetes Mellitus (DM) in the world in 2010, which is forecast to grow to reach nearly 439 million in 2030. In developing countries such as India and China, the prevalence of diabetes varies from 14% to 20%. It has been estimated by the World Health Organization (WHO), that the prevalence of diabetes in developing countries will be 228 million in 2030, which is more than 50% of total estimated prevalence. The rapidly aging population is another factor contributing to the high prevalence of renal failure, especially in the developed parts of the world. According to the United Nations (UN), the aging population contributes to 21% of the total population in developed countries, against the world average of 11%. Developing and the least developed countries are below the world average at 8% and 5% respectively.

The global renal dialysis equipment market is dominated by a few big multinational companies with nearly 75% of total market share. The remaining 25% of the market is comprised of small and local players. Fresenius Medical Care AG & Co. KGaA is the market leader with a 30% share. The company offers various pieces of dialysis equipment as well as dialysis services at its dialysis clinic chain. Baxter International is the second largest market player with a 19% share. Baxter mainly operates in the peritoneal dialysis (PD) solutions market. Gambro AG is the third largest company with an 18% share, followed by B. Braun Melsungen AG which has a 9% share. Some other companies operating in the market are Asahi Kasei Corporation, Nipro Corporation and Sorin Group.

The global renal dialysis equipment market has some products in the pipeline targeting clinical unmet needs especially for physicians who perform dialysis. Updated versions of dialysis machines with improved functionality, user friendly software, and improved accessories in terms of safety and durability are expected to increase operational efficiencies. However, there is no product in the pipeline which can significantly impact dialysis treatment in terms of Quality of Life (QoL), morbidity or mortality.

GlobalData’s new report, “Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key data, information and analysis on the global renal dialysis equipment market. The report provides market landscape, competitive landscape and market trends information the renal dialysis equipment market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

For further details, please click or add the below link to your browser:

http://www.globaldata.com/reportstore/Report.aspx?ID=Global-Renal-Dialysis-Equipment-Pipeline-Analysis-Opportunity-Assessment-and-Market-Forecasts-to-2016&ReportType=Industry_Report&coreindustry=ALL&Title=Medical_Devices

Visit our report store: http://www.globaldata.com/reportstore